v3.26.1
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Operating activities:    
Net income (loss) $ 25,783 $ (270,377)
Adjustments to reconcile net income (loss) to cash used for operating activities:    
Depreciation and amortization 73,037 77,814
Stock-based compensation 3,617 2,762
Deferred income tax 664 (26,440)
Goodwill impairment charges 0 302,284
Other, net 4,640 9,203
Changes in assets and liabilities:    
Increase in accounts receivable (8,685) (1,727)
(Increase) decrease in inventory (21,129) 5,261
Increase in other current assets (4,430) (7,228)
(Decrease) increase in accounts payable (2,365) 144
Decrease in accrued liabilities (7,601) (9,725)
Change in income taxes (6,629) (21)
Other, net 366 (5,307)
Cash provided by operating activities 57,268 76,643
Investing activities:    
Capital expenditures (33,066) (40,996)
Proceeds from disposition of capital assets 62 361
Cash used for investing activities (33,004) (40,635)
Financing activities:    
Borrowings under credit facility 141,500 170,000
Repayments of credit facility borrowings (164,250) (213,750)
Repayments of other long-term debt (3,316) (1,962)
Common stock dividends paid (10,916) (11,233)
Purchase of treasury stock (1,707) (29,248)
Proceeds from (Payment for) Other Financing Activity (704) (1,186)
Cash used for financing activities (39,393) (87,379)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,228 16,302
Decrease in cash, cash equivalents and restricted cash (13,901) (35,069)
Cash, cash equivalents and restricted cash at beginning of period 78,118 102,995
Cash, cash equivalents and restricted cash at end of period $ 64,217 $ 67,926